Pipeline

Project Indication Pre-Clinical Phase 1 Phase 2 Phase 3 Regulatory Approval
BL-8040 Stem Cell Mobilization
Consolidation AML
Maintenance AML
Gastric cancer
Pancreatic cancer
AGI-134 Solid tumors

BL-8040

BL-8040, a 14-amino acid synthetic cyclic peptide, is a novel, best in class, high-affinity CXCR4 antagonist with long ...

INDICATIONS : 5

CLINICAL STUDIES : 14

AGI-134

AGI-134 is a synthetic αGal immunotherapy in development for solid tumors. AGI-134 harnesses the body’s pre-existing, highly abu...

INDICATIONS : 1

CLINICAL STUDIES : 1